New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Which pharmaceutical drugs have the most drug patents in Austria?

This chart shows the drugs with the most patents in Austria. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in A…


Making Medicines Affordable: A National Imperative

Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…


Unapproved Drugs: Opportunities for Rapid Approval and Market Exclusivity

Contrary to popular belief, there are many unapproved drugs which are actively being used. Many physicians may not even realize that that the drugs they are prescribing have not been…
The post Unapproved Drugs: Opportunities for Rapid Approval an…


Strategies for Pharmaceutical Companies to Boost Their Exports

Changes in the pharmaceutical sales model have forced leaders to invest in new selling strategies in recent years. However most of these New Commercial Models (NCMs) have not produced enough…
The post Strategies for Pharmaceutical Companies to Bo…


Patent Protection Strategies

This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…


New patent for Corcept Therap drug KORLYM

Annual Drug Patent Expirations for KORLYM Korlym is a drug marketed by Corcept Therap and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent for Corcept Therap drug KORLYM appeared first on DrugPat…


New patent for Ge Healthcare drug MYOVIEW

Annual Drug Patent Expirations for MYOVIEW Myoview is a drug marketed by Ge Healthcare and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Ge Healthcare drug MYOVIEW appeared first on …


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: